Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by New York Medical College
Sponsor:
Collaborators:
Children's Research Institute
Baylor College of Medicine
M.D. Anderson Cancer Center
Beckman Research Institute
Johns Hopkins University
Ohio State University
University of Utah
University of Michigan
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College
ClinicalTrials.gov Identifier:
NCT01636388
First received: June 26, 2012
Last updated: October 28, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)